Patent classifications
C07F7/083
Carbohydrate crosslinker
The invention relates to a hydrogel product comprising glycosaminoglycan molecules as the swellable polymer, wherein the glycosaminoglycan molecules are covalently crosslinked via crosslinks comprising a spacer group selected from the group consisting of di-, tri-, tetra-, and oligosaccharides.
SUBSTITUTED THIOPHENECARBOXAMIDES AND ANALOGUES AS ANTIBACTERIALS AGENTS
The present disclosure relates to substituted thiophene carboxamides and analogues thereof of formula (II) that may be used for protecting plants from bacterial diseases, in particular from bacterial diseases caused by bacteria belonging to the genus Xanthomonas.
##STR00001##
SUBSTITUTED THIOPHENECARBOXAMIDES AND ANALOGUES AS ANTIBACTERIALS AGENTS
The present disclosure relates to substituted thiophene carboxam-ides and analogues thereof of formula (I) that may be used for protecting plants from bacterial diseases, in particular from bacterial diseases caused by bacteria belonging to the genus Xanthomanoas.
##STR00001##
Substituted thiophenecarboxamides and analogues as antibacterials agents
The present disclosure relates to substituted thiophene carboxamides and analogues thereof of formula (I) that may be used for protecting plants from bacterial diseases, in particular from bacterial diseases caused by bacteria belonging to the genus Xanthomonas. ##STR00001##
HYDROGEN BOND INDUCED HIGH STABILITY POROUS COVALENT ORGANIC GEL MATERIAL AND PREPARATION METHOD THEREOF
A hydrogen bond induced high stability porous covalent organic gel material and a preparation method thereof are provided. The method comprises: dissolving tetrakis(4-carboxyphenyl)silane in methanol to obtain solution A; adding concentrated sulfuric acid to the solution A, then water-bath heating and re-flowing to obtain a solution B; evaporating the solution B, dissolving remaining powder with an ethyl acetate, washing and drying, filtering and then evaporating the filtrate until crystallization to obtain a colorless solid C; dissolving the colorless solid C and hydrazine hydrate in methanol, water-bath re-fluxing, filtering and collecting white powder, washing and drying to obtain a white solid D; adding the white solid D and 1,4-Phthalaldehyde to N,N-dimethyl-formamide, adding trifluoroacetic acid, and then getting the desired material. The material is has high synthesis efficiency, abundant functional groups, a large specific surface area, a good adsorption performance, and excellent chemical stability and thermal stability.
METHOD FOR DEACETYLATION OF BIOPOLYMERS
A method for at least partial deacetylation of a biopolymer comprising acetyl groups, including: a1) providing a biopolymer including acetyl groups; a2) reacting the biopolymer including acetyl groups with hydroxylamine (NH.sub.2OH) or a salt thereof at a temperature of 100° C. or less for 2-200 hours to form an at least partially deacetylated biopolymer; and a3) recovering the at least partially deacetylated biopolymer.
PROCESS FOR PREPARING MANNOSE DERIVATIVES
The invention relates to a process to prepare a compound of the following formula (I): (I), in which P represents a protective group of a hydroxyl function which is a —COR.sup.1 group with R.sup.1 representing an aryl or a (C.sub.1C.sub.6)alkyl, R represents a hydrogen atom or a protective group of a terminal alkyne, from mannose, comprising the following steps: (a) protecting the 5 hydroxyl groups of the mannose by a protective group P; (b) coupling the protected mannose obtained at step (a) with a compound of the following formula (II). The present invention also relates to a compound of formula (IIIa).
##STR00001##
Processes for Preparing Jak Inhibitors and Related Intermediate Compounds
The present invention is related to processes for preparing chiral substituted pyrazolyl pyrrolo[2,3-d]pyrimidines of Formula III, and related synthetic intermediate compounds. The chiral substituted pyrazolyl pyrrolo[2,3-d]pyrimidines are useful as inhibitors of the Janus Kinase family of protein tyrosine kinases (JAKs) for treatment of inflammatory diseases, myeloproliferative disorders, and other diseases.
##STR00001##
INDOLE COMPOUNDS, PROCESS FOR THE PREPARATION AND USE THEREOF
The present invention relates to an indole compound of Formula (I) or pharmaceutically acceptable salt thereof, and process for the preparation thereof. The present invention also relates to a pharmaceutical composition of indole compound of Formula (I) or pharmaceutically acceptable salt thereof for treating mycobacterial infection or antimalarial infection or antifungal infection in a subject in need thereof.
##STR00001##
Halogen-containing metathesis catalysts and methods thereof
The present disclosure provides compounds, compositions, and methods for preparing alkenyl halides and/or haloalkyl-substituted olefins with Z-selectivity. The methods are particularly useful for preparing alkenyl fluorides such as CF.sub.3-substituted olefins by means of cross-metathesis reactions using halogen-containing molybdenum and tungsten complexes.